Pediatr. praxi. 2025;26(6):405-410 | DOI: 10.36290/ped.2025.078

(Un)realistic intravenous administration of paracetamol syrup

Mgr. Bc. Vojtěch Fišera, MBA1, PharmDr. Kateřina Langmaierová2, MUDr. Andrea Vlčková3, Ing. Andrea Novotná Rychtecká3, Mgr. Marie Lulková4
1 Úsek ředitele UL - manažer kvality, Krajská zdravotní, a. s. - Masarykova nemocnice v Ústí nad Labem, o. z.
2 Oddělení klinické farmacie, Krajská zdravotní, a. s.
3 Oddělení soudního lékařství a toxikologie, Krajská zdravotní, a. s. - Masarykova nemocnice v Ústí nad Labem, o. z.
4 Dětská klinika FZS UJEP, Krajská zdravotní, a. s. - Masarykova nemocnice v Ústí nad Labem, o. z.

This study analyzes an alleged intravenous administration of paracetamol syrup in pediatric care. Experimental testing demonstrated that due to high viscosity and excipients, such administration is not technically feasible. The results exclude intravenous absorption and confirm the correct conduct of healthcare staff. This case highlights the importance of quality management and the necessity of objective evidence in clinical practice

Keywords: adverse drug event, paracetamol syrup, intravenous administration, forensic medicine, quality management, pediatrics.

Accepted: December 10, 2025; Published: December 15, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fišera V, Langmaierová K, Vlčková A, Rychtecká AN, Lulková M. (Un)realistic intravenous administration of paracetamol syrup. Pediatr. praxi. 2025;26(6):405-410. doi: 10.36290/ped.2025.078.
Download citation

References

  1. Taylor J, Blockman M. Wrong-route drug administration errors: A review of the literature. South African Medical Journal. 2023;113(12):e1043. Available from: https://doi.org/10.7196/SAMJ.2023.v113i12.1043. Go to original source... Go to PubMed...
  2. El Mazloum D, Boner A, Pietrobelli A. Accidental intravenous administration of paracetamol syrup in a child. Archives de Pédiatrie. 2016;23(12):1251-1253. doi: 10.1016/j.arcped.2016.09.008. Go to original source... Go to PubMed...
  3. Lavonas EJ, Reynolds KM, Dart RC. Therapeutic acetaminophen is not associated with liver injury in children: A systematic review. Pediatrics. 2010;126(6):e1430-1444. doi: 10.1542/peds.2009-3352. Go to original source... Go to PubMed...
  4. Lall SB, Paul R. Paracetamol poisoning in children. Indian Journal of Pediatrics. 1998;65(3):393-400. doi: 10.1007/BF02761194. Go to original source...
  5. Chiappini E, Bestetti M, Masi S, et al. Discomfort relief after paracetamol administration in febrile children admitted to a third-level paediatric emergency department. Front Pediatr. 2023;11:1075449. doi: 10.3389/fped.2023.1075449. Go to original source... Go to PubMed...
  6. Aouinti I, Dahmani I, Zgolli F, et al. Polyethylene glycol hypersensitivity: A diagnostic and management dilemma. Revue Française d'Allergologie. 2024. Available from: https://www.sciencedirect.com/science/article/pii/S1877032024002021. Go to original source...
  7. Pokorná A, Dolanová D, Štrombáchová V, et al. Management nežádoucích událostí ve zdravotnictví: metodika prevence, identifikace a analýza. 1. vyd. Praha: Grada Publishing, a.s.; 2019. 247 s. ISBN 978-80-271-0720-9.
  8. Patel A. Is paracetamol being prescribed and used at the correct therapeutic dose in the children population in South Africa? Western Cape University, MSc Thesis. 2014.
  9. Badgery-Parker T, Li L, Fitzpatrick E, et al. Child age and risk of medication error: A multisite children's hospital study. J Pediatr. 2024. Available from: https://www.sciencedirect.com/science/article/pii/S0022347624001902. Go to original source... Go to PubMed...
  10. Mensa M, Judit R, Lara B, et al. 3PC-042 Sterile and non-sterile compounding: risk analysis and improvement measures. Eur J Hosp Pharm. 2024. Available from: https://ejhp.bmj.com/content/31/Suppl_1/A48.2.abstract. Go to original source...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.